Scientific article
French

Dépistage du cancer de la prostate: actualité

Published in

Revue médicale suisse, vol. 5, no. 228, p. 2438-2441

Publication date

2009

Abstract

Prostate cancer screening using PSA is controversial because of a low specificity and detection of non clinically relevant cancer. Two important studies have been published recently. One of two studies suggests a 20% lowering in specific prostate cancer mortality due to PSA screening. This benefit is relevant but implies at a high risk of overtreatment and treatment-related complications. Currently PSA screening is only proposed as an individual screening for informed patients.

Keywords

  • Humans
  • Male
  • Prostate-Specific Antigen/blood
  • Prostatic Neoplasms/blood/diagnosis

Citation (ISO format)

TAWADROS, T et al. Dépistage du cancer de la prostate: actualité. In: Revue médicale suisse, 2009, vol. 5, n° 228, p. 2438–2441.

Main files (1)

Article (Published version)

Identifiers

Additional URL for this publication

http://rms.medhyg.ch/numero-228-page-2438.htm

Journal ISSN

1660-9379
446views
0downloads

Technical informations

Creation

31/10/2013 15:55:00

First validation

31/10/2013 15:55:00

Update

14/03/2023 20:45:13

Status update

14/03/2023 20:45:13

Last indexation

30/10/2024 15:29:45
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated